These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells].
    Author: Fràter-Schröder M, Müller G, Birchmeier W, Böhlen P.
    Journal: Schweiz Med Wochenschr; 1986 Aug 23; 116(34):1160-2. PubMed ID: 3464090.
    Abstract:
    Recent data indicate that beta type transforming growth factor (TGF-beta) may be a bifunctional regulator of cellular growth: it induces anchorage-independent growth of certain cells but is also capable of inhibiting anchorage-dependent or -independent proliferation of a variety of normal epithelial and transformed cells. We show that TGF-beta is also a reversible inhibitor of proliferation of bovine aortic endothelial cells in culture. TGF-beta inhibits the proliferation of endothelial cells grown in the presence of basic fibroblast growth factor (bFGF). Dose-dependent inhibition occurs at 0.2-2.0 ng/ml TGF-beta. Inhibition of cell proliferation in the presence of a maximally stimulating dose of bFGF is not overcome by a tenfold excess of bFGF, suggesting that antagonism of bFGF-induced cell proliferation by TGF-beta is of a non-competitive nature. TGF-beta affects the morphology of confluent cells in a reversible manner.
    [Abstract] [Full Text] [Related] [New Search]